Imed Infinity Medical-Limited Partnership (TLV:IMED)
Israel
· Delayed Price · Currency is ILS · Price in ILA TLV:IMED Statistics
Total Valuation
TLV:IMED has a market cap or net worth of ILS 5.04 million. The enterprise value is 1.82 million.
| Market Cap | 5.04M |
| Enterprise Value | 1.82M |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLV:IMED has 4.04 million shares outstanding. The number of shares has increased by 2.10% in one year.
| Current Share Class | 4.04M |
| Shares Outstanding | 4.04M |
| Shares Change (YoY) | +2.10% |
| Shares Change (QoQ) | -1.41% |
| Owned by Insiders (%) | 20.91% |
| Owned by Institutions (%) | 20.34% |
| Float | 2.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 33.77 |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.87 |
| EV / Sales | 12.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.00
| Current Ratio | 8.00 |
| Quick Ratio | 8.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.35% and return on invested capital (ROIC) is -4.64%.
| Return on Equity (ROE) | -7.35% |
| Return on Assets (ROA) | -4.57% |
| Return on Invested Capital (ROIC) | -4.64% |
| Return on Capital Employed (ROCE) | -7.71% |
| Revenue Per Employee | 2,133 |
| Profits Per Employee | -29,919 |
| Employee Count | 70 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +32.00% in the last 52 weeks. The beta is 0.30, so TLV:IMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +32.00% |
| 50-Day Moving Average | 120.98 |
| 200-Day Moving Average | 104.52 |
| Relative Strength Index (RSI) | 48.85 |
| Average Volume (20 Days) | 17,783 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TLV:IMED had revenue of ILS 149,334 and -2.09 million in losses. Loss per share was -0.51.
| Revenue | 149,334 |
| Gross Profit | 149,334 |
| Operating Income | -2.12M |
| Pretax Income | -2.09M |
| Net Income | -2.09M |
| EBITDA | n/a |
| EBIT | -2.12M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 3.22 million in cash and n/a in debt, giving a net cash position of 3.22 million or 0.80 per share.
| Cash & Cash Equivalents | 3.22M |
| Total Debt | n/a |
| Net Cash | 3.22M |
| Net Cash Per Share | 0.80 |
| Equity (Book Value) | 27.44M |
| Book Value Per Share | 6.80 |
| Working Capital | 2.86M |
Cash Flow
| Operating Cash Flow | -2.33M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,417.08% |
| Pretax Margin | -1,402.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TLV:IMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.10% |
| Shareholder Yield | n/a |
| Earnings Yield | -41.52% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TLV:IMED has an Altman Z-Score of 4.47.
| Altman Z-Score | 4.47 |
| Piotroski F-Score | n/a |